3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
4
Melanoma
2
Lymphoma, Non-Hodgkin
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Ovarian Neoplasms
1
Osteosarcoma
1
Osteoporosis
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hepatoblastoma
1
Hematopoietic and Lymphoid System Neoplasm
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Clinical Stage III Cutaneous Melanoma AJCC v8
1
Carcinoma, Renal Cell
1
Interventions
Lenalidomide
7
Dexamethasone
5
daratumumab
4
Calcium Dobesilate
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
auricularum
3
Curcumin
3
isatuximab
2
iberdomide
2
Leflunomide
2
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
fludarabine phosphate
1
fludarabine
1
citarinostat
1
Watchful Waiting
1
Urination
1
Stem Cell Transplantation
1
Resistance Training
1
Propranolol
1
Probiotics
1
Peripheral Blood Stem Cell Transplantation
1
PVX-410 vaccine
1
Observation
1
Metformin
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Absorptiometry, Photon
×
1 year
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts